site news

JAMA Study Finds Robotic Cystectomy Survival Rates Better Than Open

Date : May 27, 2022

In a report published on May 15, 2022, a team of UK researchers led by James W. F. Catto, PhD release their findings of a random clinical trial of over 300 patients with nonmetastastic bladder cancer. The patients were recruited from 2017 to 2020, with follow up studies at 90 days, 6 months and 12 months. About half received open radical cystectomies, the rest were treated robotically. The final follow-up was in September, 2021. The robotic patients fared better than the open patients in this study.

From the Abstract:

Conclusions and Relevance: Among patients with nonmetastatic bladder cancer undergoing radical cystectomy, treatment with robot-assisted radical cystectomy with intracorporeal urinary diversion vs open radical cystectomy resulted in a statistically significant increase in days alive and out of the hospital over 90 days. However, the clinical importance of these findings remains uncertain.

We invite you to access the complete JAMA report, by using this link: